Artificial Tears Market Trend Shows Outstanding Growth at a CAGR of 5.5% by 2030 | Exactitude Consultancy
The Exactitude Consultancy has updated its global market reports with latest data for 2024 and projections up to 2030
LUTON, BEDFORDSHIRE, UNITED KINGDOM, April 3, 2024 /EINPresswire.com/ -- The global artificial tears market size is projected to grow from USD 2.89 billion in 2023 to USD 4.20 billion by 2030, exhibiting a CAGR of 5.5% during the forecast period.
Artificial tears refer to a wide range of lubricating eye products which are often administered to the patients to relieve the symptoms of dryness in eyes and irritation of ocular surface. Artificial tears are especially critical as an ophthalmic treatment as a significant proportion of the global population is suffering from the problem of dry eye syndrome and other ocular problems such as eye allergies. As a significant proportion is over the counter products, it can be self-administered and further reduces the additional economic burden on the healthcare system. This has led to the increasing presence of numerous companies in the R&D initiatives for these products leading to launches of more sophisticated versions of eye drops, aiding global market growth during the forecast period.
๐๐จ๐ฐ๐ง๐ฅ๐จ๐๐ ๐๐๐ฆ๐ฉ๐ฅ๐ ๐๐๐ฉ๐จ๐ซ๐ญ ๐ข๐ง ๐๐๐ ๐ ๐จ๐ซ๐ฆ๐๐ญ:
https://exactitudeconsultancy.com/reports/41377/artificial-tears-market/#request-a-sample
๐๐๐๐๐ข๐ง๐ ๐๐๐ฒ ๐ฉ๐ฅ๐๐ฒ๐๐ซ๐ฌ ๐ข๐ง๐๐ฅ๐ฎ๐๐๐ ๐ข๐ง ๐ญ๐ก๐ข๐ฌ ๐๐๐ฉ๐จ๐ซ๐ญ ๐๐ซ๐:
Major players in the Artificial Tears Market are identified through secondary research and their market revenues determined through primary and secondary research are: Allergan,Bausch + Lomb,Novartis AG,Johnson & Johnson,Alcon,Santen Pharmaceutical Co., Ltd.,Ocusoft, Inc.,Thea Pharmaceuticals,Akorn Pharmaceuticals,Similasan Corporation,Visine,Prestige Consumer Healthcare Inc.,Bayer AG,Ophthalmic Specialty Group,Rohto Pharmaceutical Co., Ltd.,TheraTears,OCuSOFT Inc.,Scope Ophthalmics Ltd.,Laboratoires Thรฉa,SIFI S.p.A., among others.
๐๐๐๐๐ง๐ญ ๐๐๐ฏ๐๐ฅ๐จ๐ฉ๐ฆ๐๐ง๐ญ๐ฌ:
January 2022, Alcon Inc launched systane artificial tear drops in Europe, which are completely preservative-free lubricant eye drops.
November 2022, Allergan plc is going to acquire Kythera Biopharmaceuticals at USD 75 per Kythera share, which is approximately USD 2.1 billion.
๐๐ซ๐ญ๐ข๐๐ข๐๐ข๐๐ฅ ๐๐๐๐ซ๐ฌ ๐๐๐ซ๐ค๐๐ญ ๐๐๐ ๐ฆ๐๐ง๐ญ๐๐ญ๐ข๐จ๐ง:
Artificial Tears Market ๐ฏ๐ ๐ง๐๐ฝ๐ฒ
Polyethylene Glycols and Polypropylene Glycols
Cellulose
Other
Artificial Tears Market ๐ฏ๐ ๐๐ฒ๐น๐ถ๐๐ฒ๐ฟ๐ ๐ ๐ฒ๐๐ต๐ผ๐ฑ
Eye Drops
Ointments
๐๐๐ซ๐ค๐๐ญ ๐๐ฒ๐ง๐๐ฆ๐ข๐๐ฌ
๐ช๐ต๐ฎ๐ ๐ฎ๐ฟ๐ฒ ๐๐ต๐ฒ ๐ฝ๐ฟ๐ถ๐บ๐ฎ๐ฟ๐ ๐ณ๐ฎ๐ฐ๐๐ผ๐ฟ๐ ๐ฑ๐ฟ๐ถ๐๐ถ๐ป๐ด ๐๐ต๐ฒ ๐๐ฟ๐๐ถ๐ณ๐ถ๐ฐ๐ถ๐ฎ๐น ๐ง๐ฒ๐ฎ๐ฟ๐ ๐ ๐ฎ๐ฟ๐ธ๐ฒ๐?
๐ฑ๐๐๐๐๐ ๐ฏ๐๐พ๐๐บ๐ ๐พ๐๐ผ๐พ ๐๐ฟ ๐ฃ๐๐ ๐ค๐๐พ ๐ฃ๐๐๐พ๐บ๐๐พ
The rising incidence of dry eye syndrome, which is anticipated to increase demand for the market, is one of the main factors driving the global market. Despite the fact that dry eye syndrome is not a disorder that poses a life-threatening risk, it does affect the quality of life for those who have it. In many nations around the world, the prevalence of dry eye syndrome has been estimated, with the prevalence ranging between 9.5 and 90%, according to a report published in the research journal BMC Ophthalmology in January 2020. Such trends and statistical data have shown that there are many current and potential patients worldwide who are becoming more aware of this disorder. Even though this condition may not have a serious impact on the patient's vision, it frequently leads to a markedly reduced quality of life for the patient. This is anticipated to further accelerate market growth over the course of the projection period.
๐จ๐๐ผ๐๐พ๐บ๐๐๐๐ ๐จ๐๐๐พ๐๐๐พ๐ ๐ฏ๐พ๐๐พ๐๐๐บ๐๐๐๐
The increasing incidence of cataracts among the rapidly aging population globally is also positively impacting market growth. According to a recent clinical study in 2019 by the World Health Organization, cataracts are the most common reason for blindness and eye surgeries, accounting for about 47.8% of all blindness worldwide. Around 17.7 million people worldwide have had cataracts diagnosed. It is usual for patients to experience symptoms of dry eye syndrome after a few months following the cataract surgery. Thus, the demand for artificial tears is expected to increase among patients after cataract surgery.
๐ช๐ต๐ฎ๐ ๐ฎ๐ฟ๐ฒ ๐๐ต๐ฒ ๐บ๐ฎ๐ถ๐ป ๐ณ๐ฎ๐ฐ๐๐ผ๐ฟ๐ ๐๐ต๐ฎ๐ ๐๐ถ๐น๐น ๐๐น๐ผ๐ ๐ฑ๐ผ๐๐ป ๐๐ต๐ฒ ๐๐ฟ๐๐ถ๐ณ๐ถ๐ฐ๐ถ๐ฎ๐น ๐ง๐ฒ๐ฎ๐ฟ๐ ๐ ๐ฎ๐ฟ๐ธ๐ฒ๐?
๐ฒ๐๐ฝ๐พ ๐ค๐ฟ๐ฟ๐พ๐ผ๐๐ ๐๐ฟ ๐ ๐๐๐๐ฟ๐๐ผ๐๐บ๐ ๐๐พ๐บ๐๐
Some of the most important restrictions include product safety issues, which force users to use them with caution. Risks of contamination and unfavorable reactions from the product's preservatives are just a couple of the safety issues related to teardrops. Due to these safety concerns, usage is constrained, and the various ocular conditions may result in decreased productivity, which has a negative impact on quality of life. These restrictions are anticipated to reduce the demand for these goods, which can limit the market's expansion throughout the forecast period.
๐ช๐ต๐ฎ๐ ๐ฎ๐ฟ๐ฒ ๐๐ต๐ฒ ๐ณ๐๐๐๐ฟ๐ฒ ๐ผ๐ฝ๐ฝ๐ผ๐ฟ๐๐๐ป๐ถ๐๐ถ๐ฒ๐ ๐ณ๐ผ๐ฟ ๐๐ฟ๐๐ถ๐ณ๐ถ๐ฐ๐ถ๐ฎ๐น ๐ง๐ฒ๐ฎ๐ฟ๐ ๐ ๐ฎ๐ฟ๐ธ๐ฒ๐?
๐จ๐๐ผ๐๐พ๐บ๐๐๐๐ ๐ณ๐พ๐ผ๐๐๐๐ ๐๐๐๐ผ๐บ๐ ๐ ๐ฝ๐๐บ๐๐ผ๐พ๐๐พ๐๐๐
Consistent releases of cutting-edge and ground-breaking products from top businesses will also play a significant role in driving the global market during the forecast period. Such frequent releases of cutting-edge products have consistently raised patient population awareness. Sturdy demand for these products has resulted from this. The market's potential may be further increased by cutting-edge therapies and products for a variety of ocular conditions like dry eye syndrome and conjunctivitis. Recent launches from the SYSTANE family, like SYSTANE HYDRATION PF, and the Refresh family of artificial tears, like REFRESH RELIEVA, are two examples of recent launches that are anticipated to spur market growth during the forecast period.
๐๐ซ๐ญ๐ข๐๐ข๐๐ข๐๐ฅ ๐๐๐๐ซ๐ฌ ๐๐๐ซ๐ค๐๐ญ ๐๐ซ๐๐ง๐๐ฌ
One of the most critical trends in the global market for artificial tears is the strong consumer awareness of ocular diseases such as dry eye syndrome which diminishes the patientโs quality of life. This trend awareness of dry eye syndrome has been driven by the main companies involved in the production and also further boosted by critical governmental agencies. For instance, in the U.S., the month of July is celebrated as the โNational Dry Eye Awareness Monthโ, an initiative that is supported by the countryโs critical health agency, National Institutes of Health (NIH). Thus, such initiatives help in spreading awareness regarding the dry eye syndrome disease and measures that can be implemented to alleviate the disease effectively. Such trends are expected to significantly boost the sales of the market during the forecast period.
๐๐๐ ๐ข๐จ๐ง๐๐ฅ ๐๐ฎ๐ญ๐ฅ๐จ๐จ๐ค:
North America region is the highest contributor to the market and is expected to grow at a healthy CAGR during the forecast period. This can be attributed to the high adoption of treatment therapies and the presence of a favorable reimbursement framework. Dry eye disease is one of the most prevalent conditions in the U.S., as nearly 30% of the U.S. population suffers from dry eye disease. This is further supported by increasing demand for LASIK and refractive surgeries and the high adoption of contact lenses. For instance, per CDC estimates, an estimated 45 million people wear contact lenses in the country, representing high demand for artificial tears. According to a report, there are roughly 16 million diagnosed cases of dry eye diseases in the United States, or 6.8% of the adult population. Compared to men, females are more likely to experience it. Because of dry eye disease, almost 60% of patients visit eye care professionals. It is anticipated that the prevalence of risk factors, such as systemic diseases (diabetes), high digital device usage, and an aging population, will continue to rise in the U.S.A.
๐๐ซ๐จ๐ฐ๐ฌ๐ ๐๐จ๐ฆ๐ฉ๐ฅ๐๐ญ๐ ๐๐ฎ๐ฆ๐ฆ๐๐ซ๐ฒ ๐๐ง๐ ๐๐๐๐ฅ๐ ๐จ๐ ๐๐จ๐ง๐ญ๐๐ง๐ญ:
https://exactitudeconsultancy.com/reports/41377/artificial-tears-market/
๐ ๐ซ๐๐ช๐ฎ๐๐ง๐ญ๐ฅ๐ฒ ๐๐ฌ๐ค๐๐ ๐๐ฎ๐๐ฌ๐ญ๐ข๐จ๐ง๐ฌ:
โ What does this report covers?
โ Does this report estimates the current market size?
โ What are the key Segments offered in this report?
โ Which market dynamics are covered in this report?
โ Does this report offer customization?
๐๐ ๐จ๐๐๐๐ซ ๐๐ฎ๐ฌ๐ญ๐จ๐ฆ๐ข๐ณ๐๐ญ๐ข๐จ๐ง ๐จ๐ง ๐ซ๐๐ฉ๐จ๐ซ๐ญ ๐๐๐ฌ๐๐ ๐จ๐ง ๐๐ฎ๐ฌ๐ญ๐จ๐ฆ๐๐ซโ๐ฌ ๐ฌ๐ฉ๐๐๐ข๐๐ข๐ ๐ซ๐๐ช๐ฎ๐ข๐ซ๐๐ฆ๐๐ง๐ญ:
โ country-level analysis for the 5 countries of your choice.
โ competitive analysis of 5 key market players.
โ 40 free analyst hours to cover any other data point.
๐๐๐๐ ๐๐ฃ๐ ๐พ๐ค๐ข๐ฅ๐ง๐๐๐๐ฃ๐จ๐๐ซ๐ ๐๐ฃ๐ฉ๐๐ก๐ก๐๐๐๐ฃ๐๐ ๐ค๐ฃ ๐ฟ๐๐๐๐๐ง๐๐ฃ๐ฉ ๐๐๐ง๐ ๐๐ฉ๐จ? ๐๐๐ฉ ๐๐ฃ ๐ฉ๐ค๐ช๐๐ ๐ฌ๐๐ฉ๐ ๐ค๐ช๐ง ๐๐ญ๐ฅ๐๐ง๐ฉ๐จ: ๐๐ฅ๐๐๐ ๐ฉ๐ค ๐๐ฃ ๐๐ญ๐ฅ๐๐ง๐ฉ: https://exactitudeconsultancy.com/primary-research/
๐๐๐ ๐ข๐จ๐ง๐๐ฅ ๐๐ข๐ง๐ค๐ฌ:
https://exactitudeconsultancy.com/ja/reports/41377/artificial-tears-market/
https://exactitudeconsultancy.com/de/reports/41377/artificial-tears-market/
https://exactitudeconsultancy.com/ko/reports/41377/artificial-tears-market/
https://exactitudeconsultancy.com/fr/reports/41377/artificial-tears-market/
https://exactitudeconsultancy.com/zh-CN/reports/41377/artificial-tears-market/
๐๐๐จ๐ฎ๐ญ ๐๐ฌ
Exactitude Consultancy is a market research & consulting services firm which helps its client to address their most pressing strategic and business challenges. Our market research helps clients to address critical business challenges and also helps make optimized business decisions with our fact-based research insights, market intelligence, and accurate data.
๐๐จ๐ง๐ง๐๐๐ญ ๐๐ฌ:
https://bulletin.exactitudeconsultancy.com/
Irfan T
Exactitude Consultancy
+1 704-266-3234
email us here
Visit us on social media:
Twitter
LinkedIn
Distribution channels: Business & Economy, Healthcare & Pharmaceuticals Industry
Legal Disclaimer:
EIN Presswire provides this news content "as is" without warranty of any kind. We do not accept any responsibility or liability for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this article. If you have any complaints or copyright issues related to this article, kindly contact the author above.
Submit your press release